GCM
ZYME icon

Graham Capital Management’s Zymeworks ZYME Stock Holding History

Graham Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,660
Closed -$272K – 1705
2025
Q2 		$272K Buy
+21,660
New +$258K ﹤0.01% 1029
2022
Q4 		– Sell
-158,066
Closed -$972K – 1395
2022
Q3 		$972K Buy
158,066
+5,192
+3% +$31.3K 0.04% 500
2022
Q2 		$810K Buy
152,874
+15,273
+11% +$92.4K 0.03% 506
2022
Q1 		$901K Buy
+137,601
New +$1.23M 0.03% 350

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Graham Capital Management's ZYME Position: Q3 2025 in Review

Graham Capital Management sold out of Zymeworks (ZYME) in Q3 2025, closing a stake of 21,660 shares — an estimated $272K sold.

Graham Capital Management first reported a position in ZYME in Q1 2022 and held it in 4 quarters. The position peaked at $972K in Q3 2022. 183 funds tracked by Wall St. Rank hold ZYME as of Q3 2025.

  • Graham Capital Management reported no remaining Zymeworks position as of Q3 2025 after selling out during the quarter.
  • Graham Capital Management sold 21,660 Zymeworks shares in Q3 2025, an estimated $272K.
  • Graham Capital Management first reported a position in Zymeworks in Q1 2022 and held it in 4 quarters.
  • Graham Capital Management's Zymeworks position peaked at $972K in Q3 2022.
  • 183 funds tracked by Wall St. Rank held Zymeworks as of Q3 2025.

Based on Graham Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.